Founder, CEO Mai-Britt Zocca, PhD
Experienced biotech executive (15+y) having worked in a number of start-ups with significant insight in to translational and clinical immune oncology.
Founder, CSO and member of BoD, Professor Mads Hald Andersen
Professor and Director of CCIT (Center for Cancer Immune Therapy at Herlev University Hospital. Mads Hald Andersen has received several honors for his scientific work and is the author of more than 130 papers. MHA has founded and co-founded several spin out companies with a successful sale of Survac in 2006.